Litcius/Paper detail

Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab

Jan Leipe, Eva L. Wilke, Matthias Ebert, Andreas Teufel, Wolfgang Reindl

2020Seminars in Arthritis and Rheumatism31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRituximabCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyVirologyInternal medicineAntibodyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCancer Immunotherapy and BiomarkersSARS-CoV-2 and COVID-19 Research
Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab | Litcius